American Society for Radiation Oncology
ASTRO and AUA issue joint guideline for radiation therapy after prostatectomy
The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and ...
Cancer
May 07, 2013 |
not rated yet |
0
Hepatic function testing can assist in treatment planning for liver cancer patients
Monitoring the hepatic function of unresectable liver cancer patients, measured by 99mTc-labeled iminodiacetic acid (HIDA) via single-photon emission computed tomography (SPECT) prior to and during radiation therapy, provides ...
Cancer
Feb 08, 2013 |
not rated yet |
0
New ASTRO white paper recommends best practices to improve safety and effectiveness of IGRT
The American Society for Radiation Oncology (ASTRO) has issued a new white paper, "Assuring Safety and Quality in Image Guided Delivery of Radiation Therapy," that recommends best practices to improve the safety and effectiveness ...
Cancer
Apr 18, 2013 |
not rated yet |
0
DAI provides potential imaging biomarker to indicate brain tumor response to RT
Diffusion abnormality index (DAI) shows promise as an imaging biomarker to measure brain tumor response to radiation therapy, according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Predicting erectile dysfunction from prostate cancer treatment
Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these patients in advance of treatment ...
Cancer
Sep 27, 2012 |
not rated yet |
0
CT texture analysis of tumors may be a valuable biomarker in localized esophageal cancer
CT texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research being presented at the 2013 Cancer Imaging and Radiation ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Urology-owned radiation oncology self-referral can increase patients' travel distance for treatment
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments for their cancer when treated at a urology-owned radiation oncology practice versus other ...
Cancer
Aug 15, 2012 |
not rated yet |
0
SUVmax provides valuable indicator of progression-free survival in stage I NSCLC patients
SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Brain radiation after lung cancer treatment reduces risk of cancer spreading
Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Adding bavituximab to second-line chemotherapy doubles response rate
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) ...
Cancer
Sep 06, 2012 |
5 / 5 (2) |
0
Crizotinib reduces tumor size in patients with ALK positive lung cancer
Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
Treatment with pemetrexed, carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab (Pem+Cb+B) is no better than standard therapy with paclitaxel, carboplatin and bevacizumab followed by bevacizumab ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients
A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Stage I NSCLC patients who receive radiation therapy are surviving longer
Stage I, non-small cell lung cancer (NSCLC) patients who received radiation therapy have an increased median survival of 21 months compared to 16 months, and the percentage of patients who receive no treatment declined from ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Hispanic lung cancer patients have higher survival than non-Hispanic white patients
Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry (CCR) database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a higher overall survival ...
Cancer
Sep 06, 2012 |
not rated yet |
0